Simplex Trading’s NeuBase Therapeutics NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-670
Closed -$14K – 11149
2022
Q2
$14K Sell
670
-30
-4% -$704 ﹤0.01% 8000
2022
Q1
$26K Buy
700
+530
+312% +$18.3K ﹤0.01% 7959
2021
Q4
$9K Sell
170
-265
-61% -$17.8K ﹤0.01% 9154
2021
Q3
$41K Hold
435
– – ﹤0.01% 7771
2021
Q2
$41K Buy
+435
New +$48K ﹤0.01% 7903
2021
Q1
– Sell
-1
Closed -$181 – 8402
2020
Q4
$17K Buy
+1
New +$162 ﹤0.01% 7094
2017
Q2
– Hold
0
– -$2K – 6954
2017
Q1
– Hold
0
– – – 5392
2016
Q4
– Sell
-1
Closed -$1K – 6704
2016
Q3
$1K Buy
+1
New +$1.08K ﹤0.01% 5490
2016
Q2
– Hold
0
– – – 4739
2016
Q1
– Sell
-1
Closed -$1.42K – 3496
2015
Q4
$62K Buy
+1
New +$1.54K ﹤0.01% 1758
2015
Q3
– Hold
0
– – – 3569
2015
Q2
– Sell
-1
Closed -$1.08K – 4400
2015
Q1
$5K Buy
+1
New +$3.3K ﹤0.01% 3558

Other funds holding NBSE

Simplex Trading's NBSE Position: Q2 2023 in Review

Simplex Trading sold out of NeuBase Therapeutics (NBSE) in Q2 2023, closing a stake of 86 shares.

Simplex Trading first reported a position in NBSE in Q1 2015 and held it in 18 quarters. The position peaked at $120K in Q1 2021. 27 funds tracked by Wall St. Rank hold NBSE as of Q2 2023.

  • Simplex Trading reported no remaining NeuBase Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 86 NeuBase Therapeutics shares in Q2 2023.
  • Simplex Trading first reported a position in NeuBase Therapeutics in Q1 2015 and held it in 18 quarters.
  • Simplex Trading's NeuBase Therapeutics position peaked at $120K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held NeuBase Therapeutics as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.